MedPath

Iodixanol

Generic Name
Iodixanol
Brand Names
Visipaque, Visipaque 270, Visipaque 320
Drug Type
Small Molecule
Chemical Formula
C35H44I6N6O15
CAS Number
92339-11-2
Unique Ingredient Identifier
HW8W27HTXX

Overview

Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents.

Background

Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents.

Indication

Iodixanol is a contrast agent during coronary angiography.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2021/10/01
Phase 4
UNKNOWN
2018/09/14
N/A
Completed
2018/08/15
Phase 4
Withdrawn
2017/11/06
Phase 3
Completed
Enrico Ammirati
2017/04/18
Phase 4
Terminated
2016/03/24
Not Applicable
UNKNOWN
Chinese PLA General Hospital
2015/04/01
Not Applicable
Completed
Chinese PLA General Hospital
2014/06/24
Phase 3
Completed
2013/09/04
Not Applicable
Withdrawn
VA Greater Los Angeles Healthcare System
2013/07/25
Early Phase 1
Completed
Azienda Sanitaria Locale 9, Grosseto

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
GE Healthcare Inc.
0407-2223
INTRAVASCULAR
320 mg in 1 mL
4/30/2023
GE Healthcare Inc.
0407-2222
INTRAVASCULAR
270 mg in 1 mL
4/30/2023
GE Healthcare Inc.
0407-2223
INTRAVASCULAR
320 mg in 1 mL
3/1/2024
FRESENIUS KABI USA, LLC
65219-381
INTRAVASCULAR
270 mg in 1 mL
5/31/2022
GE Healthcare Inc.
0407-2223
INTRAVASCULAR
320 mg in 1 mL
4/30/2023
GE Healthcare Inc.
0407-2222
INTRAVASCULAR
270 mg in 1 mL
4/30/2023
FRESENIUS KABI USA, LLC
65219-383
INTRAVASCULAR
320 mg in 1 mL
5/31/2022

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Iodixanol Injection
国药准字HJ20201004
化学药品
注射剂
1/15/2024
Iodixanol Injection
国药准字HJ20191032
化学药品
注射剂
1/15/2024
Iodixanol Injection
国药准字HJ20191016
化学药品
注射剂
1/15/2024
Iodixanol Injection
国药准字H20247332
化学药品
注射剂
12/31/2024
Iodixanol Injection
国药准字HJ20181170
化学药品
注射剂
1/15/2024
Iodixanol Injection
国药准字HJ20181164
化学药品
注射剂
1/15/2024
Iodixanol Injection
国药准字HJ20181169
化学药品
注射剂
1/15/2024
Iodixanol Injection
国药准字HJ20191031
化学药品
注射剂
1/15/2024
Iodixanol Injection
国药准字J20140157
N/A
注射剂
9/16/2019
Iodixanol Injection
国药准字H20203628
化学药品
注射剂
12/2/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
VISIPAQUE INJ 320MG I/ML
N/A
N/A
N/A
9/5/1998
© Copyright 2025. All Rights Reserved by MedPath